<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=319805651697215&amp;ev=PageView&amp;noscript=1">

Newly Launched...

Visit Cryoport's CoBRA Index
Cryoport transportation image

When you need confidence in your cold chain… Trust Cryoport

Request a Quote

Upcoming Events View All


World Advanced Therapies & Regenerative Medicine Congress 2017

Date: May 17-19, 2017
Location: London, UK



CAR-TCR Summit 2017

Date: September 5-8, 2017
Location: Boston, MA

The Latest From Our Blog View All

Cancer MoonShot 2020 Initiative Spurs Immunotherapy Research and Integrated Logistics Need

Providing $6.3 billion in funding for medical innovation to expedite the discovery, development and delivery of new treatments and cures, the 21st Century Cures Act (Cures) received overwhelming Congressional approval and was signed into law in December 2016.

Cold Chain Solutions for Autologous Cell Therapy Commercialization

Biopharmaceuticals are inherently fragile and temperature-sensitive, requiring exacting control of shipping and storage conditions to maintain product efficacy. This is especially critical for autologous therapies, where cold chain management solutions involving suitable packaging, storage and data collection, as well as tightly controlled logistics, are needed. As companies conduct clinical trials for these innovative therapies, it is the right time to begin building a comprehensive, integrated supply chain in anticipation of product commercialization.